Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
+$2.06B |
| 2 |
Nasdaq
NDAQ
|
+$1.76B |
| 3 |
Wells Fargo
WFC
|
+$1.1B |
| 4 |
Gilead Sciences
GILD
|
+$978M |
| 5 |
Edwards Lifesciences
EW
|
+$964M |
Top Sells
| 1 |
EOG Resources
EOG
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.75B |
| 3 |
HCA Healthcare
HCA
|
+$1.51B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 5 |
PNC Financial Services
PNC
|
+$1.29B |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 19.6% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Lamb Weston
LW
$7.96B
| $1.15M | ﹤0.01% |
17,822
-4,673
| -21% | -$303K |
|
1577
Lexicon Pharmaceuticals
LXRX
$411M
| $1.15M | ﹤0.01% |
732,747
-5,881
| -0.8% | -$9.23K |
|
1578
Monte Rosa Therapeutics
GLUE
$298M
| $1.15M | ﹤0.01% |
217,001
+50,330
| +30% | +$267K |
|
1579
Kyverna Therapeutics
KYTX
$177M
| $1.15M | ﹤0.01% |
235,123
-478,277
| -67% | -$2.34M |
|
1580
Steris
STE
$24.5B
| $1.15M | ﹤0.01% |
4,726
-544
| -10% | -$132K |
|
1581
Emergent Biosolutions
EBS
$441M
| $1.14M | ﹤0.01% |
136,289
+22,295
| +20% | +$186K |
|
1582
Strategy Inc Common Stock Class A
MSTR
$93.2B
| $1.13M | ﹤0.01% |
6,727
+497
| +8% | +$83.8K |
|
|
SWTX
1583
DELISTED
SpringWorks Therapeutics
SWTX
| $1.12M | ﹤0.01% |
34,994
+1,853
| +6% | +$59.4K |
|
1584
Tango Therapeutics
TNGX
$759M
| $1.1M | ﹤0.01% |
143,207
-6,570
| -4% | -$50.6K |
|
1585
Graham Corp
GHM
$521M
| $1.1M | ﹤0.01% |
+37,265
| New | +$1.1M |
|
|
PARA
1586
DELISTED
Paramount Global Class B
PARA
| $1.09M | ﹤0.01% |
102,406
-20,361
| -17% | -$216K |
|
|
ITOS
1587
DELISTED
iTeos Therapeutics
ITOS
| $1.08M | ﹤0.01% |
105,769
+18,255
| +21% | +$186K |
|
1588
Regency Centers
REG
$13.1B
| $1.08M | ﹤0.01% |
14,917
-30,892
| -67% | -$2.23M |
|
1589
Baxter International
BAX
$12.6B
| $1.07M | ﹤0.01% |
28,267
-2,743
| -9% | -$104K |
|
1590
iShares MSCI UAE ETF
UAE
$164M
| $1.06M | ﹤0.01% |
70,105
-7,432
| -10% | -$113K |
|
1591
MindMed
MNMD
$743M
| $1.06M | ﹤0.01% |
185,722
+109,152
| +143% | +$621K |
|
|
MOMO
1592
Hello Group
MOMO
$1.27B
| $1.05M | ﹤0.01% |
138,253
-720,876
| -84% | -$5.49M |
|
1593
Trimble
TRMB
$19.1B
| $1.05M | ﹤0.01% |
16,888
+551
| +3% | +$34.2K |
|
|
THRD
1594
DELISTED
Third Harmonic Bio
THRD
| $1.05M | ﹤0.01% |
77,370
-13,543
| -15% | -$184K |
|
1595
Aura Biosciences
AURA
$401M
| $1.04M | ﹤0.01% |
+116,392
| New | +$1.04M |
|
1596
Industrial Select Sector SPDR Fund
XLI
$23.1B
| $1.03M | ﹤0.01% |
+7,573
| New | +$1.03M |
|
1597
MasterBrand
MBC
$1.62B
| $1.02M | ﹤0.01% |
55,113
-2,177,753
| -98% | -$40.4M |
|
1598
MacroGenics
MGNX
$109M
| $1.01M | ﹤0.01% |
307,140
+41,733
| +16% | +$137K |
|
1599
BorgWarner
BWA
$9.45B
| $1M | ﹤0.01% |
27,629
+394
| +1% | +$14.3K |
|
1600
TransAlta
TAC
$3.66B
| $998K | ﹤0.01% |
+96,206
| New | +$998K |
|